Skip to content

AUPH

Aurinia Pharmaceuticals Inc.

NASDAQ · Healthcare · Biotechnology · CA

$16.08
−0.25%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$355.9K
Net value (3m)
+1.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 25, 2026Robertson Stephen P. · officer: Chief Legal OfficerSale20,975$17
Jun 8, 2026Bailey Jeffrey Allen · directorA-Award23,931$16
Jun 8, 2026Nova Tina Susan · directorA-Award23,931$16
Jun 8, 2026Johnson Craig A · directorA-Award23,931$16
Jun 8, 2026Goetz Kathleen · directorA-Award23,931$16
Jun 2, 2026TANG KEVIN · director, 10 percent owner, officer: Chief Executive OfficerPurchase262,682$15
Jun 2, 2026TANG KEVIN · director, 10 percent owner, officer: Chief Executive OfficerPurchase343,521$15
Jun 2, 2026TANG KEVIN · director, 10 percent owner, officer: Chief Executive OfficerPurchase99$15
Jun 2, 2026TANG KEVIN · director, 10 percent owner, officer: Chief Executive OfficerPurchase206,005$15
Jun 2, 2026TANG KEVIN · director, 10 percent owner, officer: Chief Executive OfficerPurchase2,299$15
May 20, 2026Robertson Stephen P. · officer: Chief Legal OfficerA-Award115,541$0.00
May 20, 2026Hearne Michael S · officer: Chief Financial OfficerA-Award70,230$15
May 20, 2026Cole Ryan · officer: Chief Operating OfficerA-Award116,144$0.00
May 20, 2026Cole Ryan · officer: Chief Operating OfficerA-Award70,230$15
May 20, 2026Hearne Michael S · officer: Chief Financial OfficerA-Award116,144$0.00
Mar 10, 2026Keenan Greg · officer: SVP, Chief Medical OfficerF-InKind8,069$14
Mar 3, 2026TANG KEVIN · directorPurchase83,561$14
Mar 3, 2026TANG KEVIN · directorPurchase184,208$14
Mar 3, 2026TANG KEVIN · directorPurchase300,000$14
Mar 3, 2026TANG KEVIN · directorPurchase1,600$14
Mar 3, 2026TANG KEVIN · directorPurchase214,839$14
Mar 3, 2026TANG KEVIN · directorPurchase115,792$14
Feb 23, 2026Robertson Stephen P. · officer: EVP, General CounselF-InKind34,638$14
Feb 23, 2026Greenleaf Peter · director, officer: Chief Executive OfficerF-InKind100,171$14
Feb 23, 2026Donley Matthew Maxwell · officer: Chief Operating OfficerF-InKind32,901$14
Feb 23, 2026Miller Joseph M · officer: Chief Financial OfficerF-InKind32,424$14
Feb 3, 2026Keenan Greg · officer: SVP, Chief Medical OfficerF-InKind11,552$15
Jan 5, 2026Robertson Stephen P. · officer: EVP, General CounselF-InKind40,385$16
Jan 5, 2026Robertson Stephen P. · officer: EVP, General CounselA-Award48,558$0.00
Jan 5, 2026Donley Matthew Maxwell · officer: Chief Operating OfficerA-Award54,166$0.00
Institutional positioning

13F filings over the trailing two quarters

New 90Increased 209Reduced 155Sold out 25
FilerActionSharesFiled
TANG CAPITAL MANAGEMENT LLCIncreased13,044,106Aug 14, 2026
TANG CAPITAL MANAGEMENT LLCIncreased12,229,500May 15, 2026
BlackRock, Inc.Increased8,193,085Aug 7, 2026
BLACKROCK, INC.Reduced7,845,521May 13, 2026
GOLDMAN SACHS GROUP INCIncreased5,619,401Aug 14, 2026
NEA MANAGEMENT COMPANY, LLCUnchanged3,969,834May 15, 2026
NEA Management Company, LLCUnchanged3,969,834Aug 14, 2026
TWO SIGMA INVESTMENTS, LPIncreased3,467,514Aug 14, 2026
TWO SIGMA INVESTMENTS, LPIncreased3,428,705May 15, 2026
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPReduced3,284,368May 14, 2026
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPReduced3,264,062Aug 13, 2026
STATE STREET CORPIncreased2,589,615Aug 7, 2026
STATE STREET CORPIncreased2,527,099May 15, 2026
MORGAN STANLEYIncreased2,308,244Aug 13, 2026
MORGAN STANLEYReduced2,232,548May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026